BGLCStockBioNexus Gene Lab Corp
Verdicts genuinely change. Free email alert the moment BGLC's does — no target price to set, unlike a price alert.
Near limit Ratio screen, 5 of 7 decided standards passing. Dow Jones Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay no verdict. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $2.0M as of 2026-11-20.
Business activity: held for review
BioNexus Gene Lab Corp appears to be a medical laboratory providing diagnostic and genetic testing services based on its SIC classification and name. However, I have limited specific knowledge of this company's actual operations, revenue streams, and whether it engages in any human cloning research or commercialization - a category I must be particularly careful about given the company's focus on genetics.
AAOIFI Fail 2 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.29% | 30.00% | Pass(20.7pp buffer) |
| Interest-bearing investments | 111.49% | 30.00% | Fail(81.5pp over) |
| Non-permissible income | 1.13% | 5.00% | Pass(3.9pp buffer) |
Usmani Pass 5 of 5 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.70% | 33.00% | Pass(30.3pp buffer) |
| Interest-bearing investments | 25.38% | 33.00% | Pass(7.6pp buffer) |
| Non-liquid assets | 74.18% | at least 20.00% | Pass(54.2pp above the floor) |
| Non-permissible income | 1.13% | 5.00% | Pass(3.9pp buffer) |
| Net liquid assets per share | $1.1M | under mkt cap $2.0M | Pass |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.12% | 33.33% | Pass(31.2pp buffer) |
| Cash + interest-bearing securities | 25.38% | 33.33% | Pass(7.9pp buffer) |
| Accounts receivable | 25.82% | 33.33% | Pass(7.5pp buffer) |
| Non-permissible income | 1.13% | 5.00% | Pass(3.9pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.62% | 33.33% | Pass(32.7pp buffer) |
| Cash + interest-bearing securities | 25.38% | 33.33% | Pass(7.9pp buffer) |
| Accounts receivable | 25.82% | 50.00% | Pass(24.2pp buffer) |
| Non-permissible income | 1.13% | 5.00% | Pass(3.9pp buffer) |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.48% | 33.00% | Pass(30.5pp buffer) |
| Cash + interest-bearing securities | 29.81% | 33.00% | Pass(3.2pp buffer) |
| Accounts receivable | 0.51% | 33.00% | Pass(32.5pp buffer) |
| Non-permissible income | 1.13% | 5.00% | Pass(3.9pp buffer) |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.12% | 33.00% | Pass(30.9pp buffer) |
| Cash + interest-bearing securities | 25.46% | 49.00% | Pass(23.5pp buffer) |
| Accounts receivable | 0.44% | 49.00% | Pass(48.6pp buffer) |
| Non-permissible income | 1.13% | 5.00% | Pass(3.9pp buffer) |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.12% | 33.33% | Pass(31.2pp buffer) |
| Cash + interest-bearing securities | 25.46% | 33.33% | Pass(7.9pp buffer) |
| Accounts receivable | 25.90% | 49.00% | Pass(23.1pp buffer) |
| Non-permissible income | 1.13% | 5.00% | Pass(3.9pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from BGLC's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $7.4M | 2025-12-31 | Revenues |
| Interest-bearing debtShort and long-term borrowings | $54.4K | 2026-09-30 | LongTermDebtAndCapitalLeaseObligations |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $2.2M | 2026-09-30 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
| Total assetsBalance sheet total | $8.8M | 2026-09-30 | Assets |
| Market capDenominator for AAOIFI | $2.0M | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $7.4M | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $6.3M | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $83.9K | 2025-12-31 | InterestIncomeOther |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-19, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-04-14, period ended 2025-12-31. Screened 2026-11-20.
-
Total assets$8.8M
Assets· period ended 2026-09-30 · 10-Q filed 2026-11-19 -
Interest-bearing debt$54.4K
LongTermDebtAndCapitalLeaseObligations· period ended 2026-09-30 · 10-Q filed 2026-11-19 -
Cash and interest-bearing securities$2.2M
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents· period ended 2026-09-30 · 10-Q filed 2026-11-19 -
Receivables$38.1K
AccountsReceivableNetCurrent· period ended 2026-09-30 · 10-Q filed 2026-11-19 -
Revenue$7.4M
Revenues· period ended 2025-12-31 · 10-K filed 2026-04-14 -
Interest income (non-permissible)$83.9K
InterestIncomeOther· period ended 2025-12-31 · 10-K filed 2026-04-14 -
Market cap$2.0MMarket quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-20 · not a filing figure, so no link
6 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.
What changed, and when
Verdict history for BGLC. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-11-20 Unverified → Pass filing re-screen
- 2026-11-20 Unverified → Fail filing re-screen
Tracked since 2026-09-07.
What would change the status
The headline verdict is the majority of the decided ratio standards — 5 pass and 2 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-20.
Within 3 points of the line
- Dow Jones Islamic cash and interest ratio: 2.6pp over
Dow Jones Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay no verdict.
The ratios that move with the share price
AAOIFI's debt ratio (9.3% against a 30% line) would only fail if the market cap fell by 69%, to $617,720.
AAOIFI's investments ratio is $2.2M cash and interest-bearing investments over a market cap of $2.0M (as of 2026-11-20), 111.5% against a 30% line.
It would pass if the market cap rose above $7.4M (+272%), about $2.12 a share against $0.57 implied by the screen's own figures.
AAOIFI would then pass, and the majority verdict would move from no verdict to Compliant (6 of 7 decided standards passing).
At the screen's market cap, it would take $1.6M less cash and interest-bearing investments to clear the line.
AAOIFI would then pass, and the majority verdict would move from no verdict to Compliant (7 of 7 decided standards passing, counting every standard that divides the same figure).
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Specialty Chemicals listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| LINLinde Plc. | $224.4B | — |
| AIQUYAir Liquide S.A - ADR | $127.3B | — |
| ECLEcolab, Inc. | $80.4B | — |
| APDAir Products & Chemicals Inc. | $68.2B | — |
| DDDuPont de Nemours Inc | $18.5B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 27.00 | BUY |
| Stochastic %K (14) | 15.99 | BUY |
| CCI (20) | -127.63 | BUY |
| Williams %R (14) | -84.01 | BUY |
| MACD (12,26,9) | -0.01 | SELL |
| ROC (10) | -18.07 | SELL |
| Momentum (10) | -0.15 | SELL |
| EMA (10) | 0.79 | SELL |
| SMA (10) | 0.80 | SELL |
| EMA (20) | 0.89 | SELL |
| SMA (20) | 0.89 | SELL |
| EMA (30) | 0.97 | SELL |
| SMA (30) | 1.01 | SELL |
| EMA (50) | 1.10 | SELL |
| SMA (50) | 1.15 | SELL |
| EMA (100) | 1.38 | SELL |
| SMA (100) | 1.36 | SELL |
| EMA (200) | 1.94 | SELL |
| SMA (200) | 1.81 | SELL |
About BioNexus Gene Lab Corp
Basic Materials · Specialty Chemicals
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 43 |
| ⏱ 15-Min | BEARISH | 55 |
| ⏲ 5-Min | BEARISH | 165 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-17 · Asset managers net 895049 (-19081)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.